153 related articles for article (PubMed ID: 19202131)
21. Activation of B cells using Schneider 2 cells expressing CD40 ligand for the enhancement of antigen presentation in vitro.
Yoon SH; Cho HI; Kim TG
Exp Mol Med; 2005 Dec; 37(6):567-74. PubMed ID: 16391518
[TBL] [Abstract][Full Text] [Related]
22. LIGHT costimulates CD40 triggering and induces immunoglobulin secretion; a novel key partner in T cell-dependent B cell terminal differentiation.
Duhen T; Pasero C; Mallet F; Barbarat B; Olive D; Costello RT
Eur J Immunol; 2004 Dec; 34(12):3534-41. PubMed ID: 15549770
[TBL] [Abstract][Full Text] [Related]
23. CD40 ligand and MHC class II expression are essential for human peripheral B cell tolerance.
Hervé M; Isnardi I; Ng YS; Bussel JB; Ochs HD; Cunningham-Rundles C; Meffre E
J Exp Med; 2007 Jul; 204(7):1583-93. PubMed ID: 17562816
[TBL] [Abstract][Full Text] [Related]
24. Preferential expression of B7.2 (CD86), but not B7.1 (CD80), on B cells induced by CD40/CD40L interaction is essential for anti-DNA autoantibody production in patients with systemic lupus erythematosus.
Nagafuchi H; Shimoyama Y; Kashiwakura J; Takeno M; Sakane T; Suzuki N
Clin Exp Rheumatol; 2003; 21(1):71-7. PubMed ID: 12673892
[TBL] [Abstract][Full Text] [Related]
25. Simultaneous targeting of CD3 on T cells and CD40 on B or dendritic cells augments the antitumor reactivity of tumor-primed lymph node cells.
Li Q; Grover AC; Donald EJ; Carr A; Yu J; Whitfield J; Nelson M; Takeshita N; Chang AE
J Immunol; 2005 Aug; 175(3):1424-32. PubMed ID: 16034078
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of B lymphocyte deficiencies.
Vickery JD; Michael CF; Lew DB
Cardiovasc Hematol Disord Drug Targets; 2013 Aug; 13(2):133-43. PubMed ID: 23988001
[TBL] [Abstract][Full Text] [Related]
27. CD73 expression identifies a subset of IgM
D'Souza L; Gupta SL; Bal V; Rath S; George A
Immunology; 2017 Dec; 152(4):602-612. PubMed ID: 28746783
[TBL] [Abstract][Full Text] [Related]
28. CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response.
Borrow P; Tishon A; Lee S; Xu J; Grewal IS; Oldstone MB; Flavell RA
J Exp Med; 1996 May; 183(5):2129-42. PubMed ID: 8642323
[TBL] [Abstract][Full Text] [Related]
29. Mucosal immunity in healthy adults after parenteral vaccination with outer-membrane vesicles from Neisseria meningitidis serogroup B.
Davenport V; Groves E; Horton RE; Hobbs CG; Guthrie T; Findlow J; Borrow R; Naess LM; Oster P; Heyderman RS; Williams NA
J Infect Dis; 2008 Sep; 198(5):731-40. PubMed ID: 18636953
[TBL] [Abstract][Full Text] [Related]
30. Impaired germinal center formation and recall T-cell-dependent immune responses in mice lacking the costimulatory ligand B7-H2.
Wong SC; Oh E; Ng CH; Lam KP
Blood; 2003 Aug; 102(4):1381-8. PubMed ID: 12714510
[TBL] [Abstract][Full Text] [Related]
31. Identification and characterization of TspA, a major CD4(+) T-cell- and B-cell-stimulating Neisseria-specific antigen.
Kizil G; Todd I; Atta M; Borriello SP; Ait-Tahar K; Ala'Aldeen DA
Infect Immun; 1999 Jul; 67(7):3533-41. PubMed ID: 10377136
[TBL] [Abstract][Full Text] [Related]
32. Induction of dendritic cell costimulator molecule expression is suppressed by T cells in the absence of antigen-specific signalling: role of cluster formation, CD40 and HLA-class II for dendritic cell activation.
McLellan AD; Heiser A; Hart DN
Immunology; 1999 Oct; 98(2):171-80. PubMed ID: 10540215
[TBL] [Abstract][Full Text] [Related]
33. Memory B cell development but not germinal center formation is impaired by in vivo blockade of CD40-CD40 ligand interaction.
Gray D; Dullforce P; Jainandunsing S
J Exp Med; 1994 Jul; 180(1):141-55. PubMed ID: 7516404
[TBL] [Abstract][Full Text] [Related]
34. Human Germinal Center B Cells Differ from Naïve and Memory B Cells in CD40 Expression and CD40L-Induced Signaling Response.
Huse K; Wogsland CE; Polikowsky HG; Diggins KE; Smeland EB; Myklebust JH; Irish JM
Cytometry A; 2019 Apr; 95(4):442-449. PubMed ID: 30838773
[TBL] [Abstract][Full Text] [Related]
35. Cross-talk between CD40 and CD40L: lessons from primary immune deficiencies.
Ferrari S; Plebani A
Curr Opin Allergy Clin Immunol; 2002 Dec; 2(6):489-94. PubMed ID: 14752331
[TBL] [Abstract][Full Text] [Related]
36. TNF-alpha blockade down-regulates the CD40/CD40L pathway in the mucosal microcirculation: a novel anti-inflammatory mechanism of infliximab in Crohn's disease.
Danese S; Sans M; Scaldaferri F; Sgambato A; Rutella S; Cittadini A; Piqué JM; Panes J; Katz JA; Gasbarrini A; Fiocchi C
J Immunol; 2006 Feb; 176(4):2617-24. PubMed ID: 16456024
[TBL] [Abstract][Full Text] [Related]
37. Expression of CD40 ligand (CD154) in B and T lymphocytes of Hodgkin disease: potential therapeutic significance.
Clodi K; Asgari Z; Younes M; Palmer JL; Cabanillas F; Carbone A; Andreeff M; Younes A
Cancer; 2002 Jan; 94(1):1-5. PubMed ID: 11815953
[TBL] [Abstract][Full Text] [Related]
38. Evidence for naturally acquired T cell-mediated mucosal immunity to Neisseria meningitidis.
Davenport V; Guthrie T; Findlow J; Borrow R; Williams NA; Heyderman RS
J Immunol; 2003 Oct; 171(8):4263-70. PubMed ID: 14530350
[TBL] [Abstract][Full Text] [Related]
39. CD4+ T lymphocytes expressing CD40 ligand help the IgM antibody response to soluble pneumococcal polysaccharides via an intermediate cell type.
Jeurissen A; Billiau AD; Moens L; Shengqiao L; Landuyt W; Wuyts G; Boon L; Waer M; Ceuppens JL; Bossuyt X
J Immunol; 2006 Jan; 176(1):529-36. PubMed ID: 16365447
[TBL] [Abstract][Full Text] [Related]
40. CD28 co-stimulation stabilizes the expression of the CD40 ligand on T cells.
Johnson-Léger C; Christensen J; Klaus GG
Int Immunol; 1998 Aug; 10(8):1083-91. PubMed ID: 9723694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
